tubocurarine has been researched along with alpha,beta-methyleneadenosine 5'-triphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birinyi-Strachan, LC; Hodgson, WC; Nicholson, GM; Rash, LD | 1 |
| Cseri, J; Csernátony, Z; Csernoch, L; Kovács, L; Szappanos, H; Szigeti, GP | 1 |
2 other study(ies) available for tubocurarine and alpha,beta-methyleneadenosine 5'-triphosphate
| Article | Year |
|---|---|
Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating.
Topics: Acetylcholine; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Chickens; Diaphragm; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Ion Channel Gating; Male; Membrane Potentials; Mice; Mice, Inbred BALB C; Muscle Contraction; Muscles; Neurotoxins; Nicotinic Antagonists; Phrenic Nerve; Potassium Chloride; Prazosin; Rats; Rats, Sprague-Dawley; Sodium Channels; Spider Venoms; Tetrodotoxin; Tubocurarine; Vas Deferens; Vasodilator Agents | 2000 |
A purinergic signal transduction pathway in mammalian skeletal muscle cells in culture.
Topics: Adenosine Triphosphate; Anesthetics, Local; Animals; Antineoplastic Agents; Calcium; Calcium Channel Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Mammals; Mice; Muscle Fibers, Skeletal; Muscle, Skeletal; Nicotinic Antagonists; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X; Signal Transduction; Tetrodotoxin; Tubocurarine; Verapamil | 2002 |